← Back to Search

Dosimetry Group for Gynecologic Cancers

Phase 2
Waitlist Available
Led By Steve Cho, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 day
Awards & highlights

Study Summary

This trial is testing how well PSMA PET and MR Imaging can detect cancer cells in people with gynecologic cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diagnostic Accuracy
Secondary outcome measures
Biodistribution of PSMA Measured by SUVmax in Cancer Tissue
Biodistribution of PSMA Measured by SUVmax in Normal Tissue
Radiodosimetry of PSMA
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Patient GroupExperimental Treatment1 Intervention
The patient group will consist of women with suspected gynecological cancers who are undergoing hysterectomy and salpingo-oophorectomy. Women will receive standard of care PSMA-based 18F-DCFPyL tracer and PET/MR imaging. n=40
Group II: Healthy Control Non-Dosimetry GroupExperimental Treatment1 Intervention
The control group will consists of women with no imaging evidence of gynecological cancer, who are undergoing hysterectomy and salpingo-oophorectomy. Women will receive PSMA-based 18F-DCFPyL tracer and PET/MR imaging. n=6
Group III: Dosimetry GroupExperimental Treatment1 Intervention
Women with or without suspected gynecological cancer. Women will receive PSMA-based 18F-DCFPyL tracer and PET/CT imaging, PET/MR imaging as needed. n=6

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,193 Previous Clinical Trials
3,161,854 Total Patients Enrolled
1 Trials studying Gynecologic Cancers
75 Patients Enrolled for Gynecologic Cancers
Steve Cho, MDPrincipal InvestigatorUniversity of Wisconsin, Madison
4 Previous Clinical Trials
24 Total Patients Enrolled
Elizabeth Sadowski, MDPrincipal InvestigatorUniversity of Wisconsin, Madison
1 Previous Clinical Trials
1,340 Total Patients Enrolled
~2 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top